CSTL CapEx to Revenue

Castle Biosciences Inc · CapEx to Revenue

CSTL logo

CSTL CapEx to Revenue

Current (TTM)12.07%
CSTL CapEx/Revenue (3.60% → 12.07%)
High-resolution chart · PNG

CSTL capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
10.4643%
8.5302%
6.1973%
4.1098%
3.702%
7.5835%
1.8066%
1.2158%
3.5979%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.